期刊文献+

左旋肉碱在人角膜缘上皮细胞的转运特性

Transport of L-carnitine in human corneal epithelial cells
下载PDF
导出
摘要 目的检测左旋肉碱(L-carnitine,LC)在人角膜缘上皮(human corneal limbal epithelia,HCLE)细胞的转运特性,为进一步阐明HCLE细胞对LC的转运机制提供实验依据。方法采用放射摄入实验检测HCLE细胞对[~3H]-L-carnitine的转运功能,并利用米氏方程(Michaelis-Menten equation)分析计算其动力学参数。结果HCLE细胞对LC的转运过程具有饱和性和时间依赖性,并且反应体系中需要Na^+的存在。Eadie-Hofstee作图提示HCLE细胞存在高亲和力和低亲合力2个肉碱转运系统。非标记LC和乙酰化左旋肉碱可竞争性抑制[~3H]-Lcarnitine的转运过程。结论 HCLE细胞可通过主动转运过程将泪液中的左旋肉碱摄入细胞内,发挥其生物学功能。 Objective To investigate the characteristics of L-carnitine(LC) import into human corneal limbal epithelia(HCLE) cells,and to provide an experimental basis for further study of transport mechanism of LC in human ocular epithelium.Methods The transport of[~3H]-L-carnitine was determined using the radio uptake assay and the apparent kinetic parameters of carnitine uptake by HCLE were estimated by nonlinear regression curve fitting according to the Michaelis-Menten equation.Results The uptake of LC into HCLE cells was saturable and time-dependent,and it also required the presence of Na~+ in the external medium.An Eadie-Hofstee plot showed two distinct components:a high- and a low-affinity carnitine transport system in HCLE cells.The unlabelled LC and acetyl-L-carnitine competitively inhibited the uptake of[~3H]-L-carnitine by HCLE cells.Conclusion L-carnitine is transported into HCLE cells from tears by an active carrier mediated transport system and exerts its biological function.
出处 《河北医科大学学报》 CAS 2015年第1期48-51,共4页 Journal of Hebei Medical University
基金 河北省医学科学研究重点课题(20130136)
关键词 左旋肉碱 上皮 角膜 胞吞转运 L-carnitine epithelium corneal transcytosis
  • 相关文献

参考文献2

二级参考文献26

  • 1ZHANG R, ZHANG H,ZHANG Z, et al. Neuroprotective effects of pre-treament with 1-carnitine and acetyl-1-camitine on ischemic injury in vivo and in vitro [ J ]. Int J Mol Sci, 2012, 13 ( 2 ) : 2078 - 2090.
  • 2REUTER SE, EVANS AM. Carnitine and acylcaxnitines: pharmacokinetic, pharmacological and clinical aspects [ J ]. Clin Pharmacokinet ,2012,51 ( 9 ) :553 - 572.
  • 3CAVE MC, HURT RT, FRAZIER TH, et al. Obesity, inflammation, and the potential application of pharmaconutrition [ J ]. Nutr Clin Pract ,2008,23 ( 1 ) : 16 - 34.
  • 4FLANAGAN JL, SIMMONS PA, VEHIGE J, et al. Role of carnitine in disease [ J ]. Nutr Metab ( Lond), 2010,7 : 30.
  • 5REBOUCHE CJ. Kinetics, pharmacokinetics and regulation of L- camitinc and acetyl-L-carnitine metabolism [ J ]. Ann N Y Acad Sci, 2004,1033:30 - 41.
  • 6BELLINGHIERI G, SANTORO D, CALVANI M, et al. Carnitine and hemodialysis[ J]. Am J Kidney Dis,2003,41 (3 Suppl 1 ) : S116 - 122.
  • 7SRINIVAS SR, PRASAD PD, UMAPATHY NS, et al. Transport of butyryl-L-earnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB (0, + ) [J]. Am J Physiol Gastrointest Liver Physiol, 2007,293 (5): G1046 - 1053.
  • 8SAHLIN K, SALLSTEDT EK, BISHOP D, et al. Turning down lipid oxidation during heavy exe}cise-what is the mechanism? [ J ]. J Physiol Pharmacol, 2008,59 ( Suppl 7 ) : 19 - 30.
  • 9NEBBIOSO M, EVANGELISTA M, LIBRANDO A, et al. Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study[J]. Biomed Pharmacother,2013,67(7) :659 -663.
  • 10XU S, FLANAGAN JL, SIMMONS PA, et al. Transport of L- carnitine in human corneal and conjunctival epithelial cells [ J ]. Mol Vis,2010,16 : 1823 - 1831.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部